FDA approves groundbreaking sickle cell anemia treatment

The FDA has approved a groundbreaking cure for sickle cell anemia called Casgevy which uses the gene-editing tool CRISPR. NBC News’ Rehema Ellis has more details on the new hope for those suffering with the debilitating blood disorder. » Subscribe to NBC News: https://www.youtube.com/user/NBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows. Connect with NBC News Online! Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621 Visit NBCNews.Com: https://www.nbcnews.com/ Find NBC News on Facebook: https://www.facebook.com/NBCNews Follow NBC News on Twitter: https://twitter.com/NBCNews Get more of NBC News delivered to your inbox: nbcnews.com/newsletters #SickleCellAnemia #GeneEditing #FDA

Try Adsterra Earnings, it’s 100% Authentic to make money more and more.